Key result
Nonstop mutations bidirectionally alter protein half-lives, reducing stability by ~28% or slightly enhancing it.
Why the study?
The impact of protein C-terminal variations on the proteome remains poorly understood, and it is unclear whether aberrant C-termini universally lead to protein degradation.
null
Effect estimate: 9.5% increase or 28.4% reduction in stability (95% CI null)
p-value: p=null
C-terminal variation is a widespread strategy for generating protein forms with distinct half-lives to exert diverse biological functions.
Protein C-termini can vary due to errors or programmed regulation, contributing to proteome diversity, yet their impact on the proteome remains poorly understood. Although aberrant C-termini are often linked to protein degradation, it is unclear if this holds true universally. In this study, we examine how C-terminal variations-arising from disease-associated nonstop mutations, alternative splicing, and translational readthrough-affect protein half-lives. Our findings indicate that, contrary to previous studies, erroneous C-termini can either stabilize or destabilize proteins. We have identified multiple oncoproteins and tumor suppressors whose protein stability is altered by disease-relevant nonstop mutations. Notably, we have found that C-terminal variations commonly influence the stability of canonical proteins, extending beyond their role in protein quality control. Furthermore, we have uncovered C-terminal features that distinguish erroneous from wild-type proteins and reveal that hydrophobic C-termini are targeted by a complex ubiquitin ligase network. Overall, our work broadens the understanding of C-terminal-dependent protein degradation and supports that C-terminal variation is a widespread strategy for generating protein forms with distinct half-lives to exert diverse biological functions.
No takes yet. Share an insight, caveat, or question.
Chu et al. (2026) conducted a null in null. null vs. null was evaluated on Protein half-life affected by C-terminal variations from nonstop mutations (9.5% increase or 28.4% reduction in stability, 95% CI null, p=null). Nonstop mutations can either enhance protein stability by 9.5% or reduce it by 28.4%, showcasing their diverse effects on protein half-lives.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: